AI, semiconductors, data centers
Technology Epileptic seizure warning developer Quadlytics raises $3.8m in Series B
Quadlytics raised ¥600m ($3.8m) in Series B to bring a wearable ECG seizure-warning system to market, starting with Australia’s NDIS.
Technology Powered Prosthetics Developer BionicM Raises $4.5 Million in Series B First Close
BionicM, a University of Tokyo spinout building powered prosthetic legs, raised ¥710M (about $4.5M) in a Series B first close ahead of its 2027 U.S. ASISTA launch.
Technology Cross Sector, developer of surveying technology for steel-frame erection, announces $4.9m in funding
Cross Sector, Nikon’s first spin-off, has raised ¥770m ($4.9m) to scale Frame Finder, a sensor service it says cuts steel column surveying to 15 seconds.
Technology Kinish, developer of rice-based dairy alternatives, raises $3m in Series A first close
Kinish, which is developing rice-based dairy alternatives, raised ¥490m ($3m) in its Series A first close to expand ice cream sales and plant-factory R&D.
Technology Fusion reactor developer Helical Fusion raises $20m in Series B second close
Fusion reactor developer Helical Fusion closed the second tranche of its Series B at ¥3.23bn ($20m), adding Fuji Electric, Fujikura and Tokyo Gas as investors.
Technology Picosecond laser developer Spectronix raises $3.3m in Series F extension round
Osaka-based Spectronix has raised ¥518m ($3.3m) in a Series F extension to scale mass production of its picosecond DUV laser oscillators.
Technology QibiTech, developer of multi-vendor robot control software, raises $3.8m in Series B
QibiTech, developer of the multi-vendor robot control software HATS, has raised around ¥600m ($3.8m) in a Series B round to expand development and sales.
Technology Autonomous robot developer LOMBY raises $2.4m in Series A
Robotics startup LOMBY raised ¥387m ($2.4m) in Series A to mass-produce LM-A, a low-speed delivery robot trialled with Seven-Eleven in Hachioji.
Technology Metagen Therapeutics, developer of ulcerative colitis drugs, raises $1.9m in second close of Series B extension
Tsuruoka-based Metagen Therapeutics has raised $1.9m from GLIN Impact Capital in its Series B extension, backing clinical development of its oral FMT drug for ulcerative colitis.
Technology AOI Biosciences raises $3m to pursue allosteric drug discovery
AOI Biosciences has raised $3m to expand its β2GPI neoself antibody test for recurrent pregnancy loss and to advance allosteric drug discovery using Toshiba's SQBM+.